Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul
1 other identifier
observational
5,000
1 country
1
Brief Summary
COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Mortality rates of COVID-19 pandemics vary between countries. It is known that mortality based on COVID-19 is higher in old population. Therefore the aim of this study to analyze the experience of 7 governmental hospitals in terms of patient characteristics, possible risk factors of mortality based on COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2020
CompletedFirst Submitted
Initial submission to the registry
July 18, 2020
CompletedFirst Posted
Study publicly available on registry
July 21, 2020
CompletedJuly 22, 2020
July 1, 2020
4 months
July 18, 2020
July 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
mortality based on COVID-19
mortality based on COVID-19 within the patients aged between 18-50 will be evaluated
3 months
Interventions
Novel Coronavirus 2019 DNA will be analyzed by PCR in nasopharyngeal swab
Eligibility Criteria
Patients who were between 18-50 years of age and were died caused by COVID-19 will be evaluated.
You may qualify if:
- accepted to participate
- patients who were proven to have COVID-19
You may not qualify if:
- declined to participate
- patients whose age under 18 or more than 50 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, 34303, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 18, 2020
First Posted
July 21, 2020
Study Start
March 10, 2020
Primary Completion
June 30, 2020
Study Completion
July 14, 2020
Last Updated
July 22, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share